Sort   by:  
 Page size 
UnknownKinase Inhibitor Treatment of Patients with Advanced Cancer Results in High Tumor Drug Concentrations and in Specific Alterations of the Tumor Phosphoproteome.
Not available
S-EPMC7072422 | biostudies-literature
UnknownWT1 mutations in T-ALL.
Not available
S-EPMC2721784 | biostudies-literature
ProteomicsDifferential activity of treatment with protein kinase inhibitors on tumor phosphotyrosine profiles in patients with advanced cancer
Mass spectrometry-based phosphoproteomics of tumor tissue lysates provides a potential personalized medicine approach based on its ability to identify activated signaling pathways and novel drug targets. We performed a pilot study (NCT01636908) to determine the effect of protein kinase inhibitors (P...
ORGANISM(S): Homo sapiens (Human) 
2019-04-18 | PXD008032 | Pride
Human Single-shot Tyrosine kinase Protein kinase inhibitor Label-free Phosphoproteomics 
UnknownRadiofrequency ablation and chemotherapy versus chemotherapy alone for locally advanced pancreatic cancer (PELICAN): study protocol for a randomized controlled trial.
Not available
S-EPMC8082784 | biostudies-literature
UnknownUnresectable Intermediate-Size (3-5 cm) Colorectal Liver Metastases: Stereotactic Ablative Body Radiotherapy Versus Microwave Ablation (COLLISION-XL): Protocol of a Phase II/III Multicentre Randomized Controlled Trial.
Not available
S-EPMC10382334 | biostudies-literature
UnknownThe Prospective Dutch Colorectal Cancer (PLCRC) cohort: real-world data facilitating research and clinical care.
Not available
S-EPMC7887218 | biostudies-literature
UnknownIndividual-patient meta-analysis of three randomized trials comparing endovascular versus open repair for ruptured abdominal aortic aneurysm.
Not available
S-EPMC4744980 | biostudies-literature
UnknownValue of risk scores in the decision to palliate patients with ruptured abdominal aortic aneurysm.
Not available
S-EPMC6055637 | biostudies-literature
UnknownSafety and efficacy of combined portal and hepatic vein embolisation in patients with colorectal liver metastases (DRAGON1): a multicentre, single-arm clinical trial.
Not available
S-EPMC12008670 | biostudies-literature
UnknownDragon 1 Protocol Manuscript: Training, Accreditation, Implementation and Safety Evaluation of Portal and Hepatic Vein Embolization (PVE/HVE) to Accelerate Future Liver Remnant (FLR) Hypertrophy.
Not available
S-EPMC9458562 | biostudies-literature
Sort   by:  
 Page size